NCI will lead the Company’s personalized TCR-T cell therapy program using the Company’s proprietary non-viral Sleeping Beauty technologyHOUSTON, June 27,…
Appointment of Dr. Peter Leddy as Executive Vice President and Chief Administrative OfficerSAN DIEGO, June 27, 2022 (GLOBE NEWSWIRE) --…
TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) is pleased to announce the…
BOCA RATON, Fla., June 27, 2022 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF),…
NEW YORK, June 27, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced data presentations highlighting data from pooled and…
– BBP-711 led to near complete inhibition of glycolate oxidase throughout the dosing period and greater than 10-fold increases in…
Industry leader brings deep expertise in international drug development, strategic leadership, and corporate partnering for biopharmaceutical companiesDURHAM, N.C., June 27,…
SAN DIEGO and TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX:…
Carson City, Nevada--(Newsfile Corp. - June 27, 2022) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a…
Toronto, Ontario and Los Angeles, California--(Newsfile Corp. - June 27, 2022) - The Tinley Beverage Company Inc. (CSE: TNY) (OTCQX:…